£9.0M
The funding round was led by Eos Advisory and includes participation from the Scottish National Investment Bank.
CO
Cumulus Oncology
Cumulus Oncology builds spin-out companies to accelerate the development of new cancer treatments.
£9.0MTotal raised
Cumulus Oncology operates Europe's first oncology biotech creation business model, designing spin-out companies to develop novel cancer treatments. The firm employs specialised portfolio strategies and advanced decision-making platforms to de-risk early-stage therapeutics.
Filed accounts
Cash at bank
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Fixed assets
Members only
Employees
Members only
Cash, assets and headcount from Cumulus Oncology's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Clare Wareing
Chief Executive Officer
Clare brings extensive oncology sector leadership experience from roles including chief executive officer of Cumulus Oncology and Nexus Oncology. She previously founded IP Oncology and held scientific and operational positions at Ockham Oncology, Chiltern, and Ilex Oncology.
LinkedIn